Breast density notification laws have taken hold in 22 states and counting, yet questions remain about which patient should receive supplemental cancer screening. A newly published study this week has shed some light on the issue, showing that not all women with dense breast are at high risk for breast cancer.

An analysis by Alavere Health estimates that new recommendations from the United States Preventative Services Task Force (USPSTF) could cause 17 million women to lose guaranteed coverage of preventive breast cancer screenings.

MRI can offer information about a patient’s future risk of developing breast cancer, which in turn could help doctors personalize screening and prevention measures for high-risk women, according to results of a study published online May 12 in Radiology.

A recent study has shown that FDG PET/CT, while useful for systemic staging of stage III ductal breast cancer, adds little to the systemic staging of invasive lobular breast cancer (ILC).

Volpara Solutions today announced the release of VolparaDensity version 3.1 here at the Society of Breast Imaging’s SBI/ACR Breast Imaging Symposium in Orlando, Fla., April 25-28, 2015 (SBI Booth #214).

Researchers have discovered that digital breast tomosynthesis (DBT) can dramatically improve breast cancer detection in women with dense breast tissue when compared to traditional mammography methods, according to results published at the ARRS 2015 Annual Meeting in Toronto.

Scientific findings and the profession’s collective knowledge regarding cancer risks from radiation exposure resulting from CT scans are uncertain at best and are not enough to justify a policy requiring informed consent from patients and guardians, according to an editorial published in the May issue of Radiology.

More than 85 percent of surgeons—both breast specialists and general surgeons—continue to follow breast cancer screening recommendations more closely aligned with those of the American Cancer Society, the American College of Radiology (ACR) and the Society of Breast Imaging, rather than those issued by the U.S. Preventive Services Task Force (USPSTF), according to results presented April 21 at the ARRS 2015 Annual Meeting in Toronto.